logo
logo

Summit Receives Investment from U. of Colorado Anschutz Medical Campus CDI Fund

Nov 18, 2020•over 4 years ago
Aurora

Description

Summit Biolabs, an early-stage molecular diagnostics company specializing in saliva liquid-biopsy tests for COVID-19 and head and neck cancer, announced they have received funding from the University of Colorado Anschutz Medical Campus (CU Anschutz), Chancellor Discovery Innovation Fund (CDI Fund).

Company Information

Company

Summit Biolabs

Location

Aurora, Colorado, United States

About

Summit Biolabs is harnessing the power of saliva-based diagnostics to address critical challenges in COVID-19 and head & neck cancer testing. Founded on the discoveries of Dr. Shi-Long Lu, Summit Biolabs is being spun out from the University of Colorado Anschutz Medical Campus.